Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

P&G Avobenzone Combos UVA Protection Data "Insufficient" - FDA

This article was originally published in The Tan Sheet

Executive Summary

Procter & Gamble efficacy data on the UVA radiation protection potential of avobenzone in combination with zinc oxide or phenylbenzimidazole sulfonic acid are not adequate to support the combos addition to the sunscreen monograph, FDA tells the company in an April 8 letter. The agency gives the firm 30 days to provide additional data, after which it will make a decision based on extant information.

You may also be interested in...



P&G Avobenzone Combo Data Demonstrate Broad Spectrum Protection - FDA

The combinations of avobenzone and either zinc oxide or phenylbenzimidazole sulfonic acid (PBSA) are safe and effective for use in sunscreens "when used in the concentrations established for each ingredient" in the sunscreen final monograph, FDA tells Procter & Gamble in a Nov. 2 letter.

P&G Avobenzone Combo Data Demonstrate Broad Spectrum Protection - FDA

The combinations of avobenzone and either zinc oxide or phenylbenzimidazole sulfonic acid (PBSA) are safe and effective for use in sunscreens "when used in the concentrations established for each ingredient" in the sunscreen final monograph, FDA tells Procter & Gamble in a Nov. 2 letter.

P&G Avobenzone Combo Data Demonstrate Broad Spectrum Protection - FDA

The combinations of avobenzone and either zinc oxide or phenylbenzimidazole sulfonic acid (PBSA) are safe and effective for use in sunscreens "when used in the concentrations established for each ingredient" in the sunscreen final monograph, FDA tells Procter & Gamble in a Nov. 2 letter.

Topics

UsernamePublicRestriction

Register

PS089712

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel